[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 5,832
Sort by:
North America: Vitamins Market US$ 1,999.00

... report on the vitamins market in North America covers the following countries: Canada, Mexico, and the United States of America. The report on the vitamins market in North America includes: Analysis and ...

August 2020 150 pages
Cephalosporins Market Research (China) US$ 4,000.00

China's demand for Cephalosporin has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...

July 2020 270 pages
Penicillin Markets in China US$ 4,000.00

China's demand for Penicillin has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...

July 2020 216 pages
Prescription Drugs Markets in China US$ 4,000.00

China's demand for Prescription Drugs has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...

July 2020 217 pages
Cephalosporin Industry Forecasts - China Focus US$ 1,800.00

This study focuses on China’s Cephalosporin industry forecasts. In the two past decades, the ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...

July 2020 135 pages
Penicillin Industry Forecasts - China Focus US$ 1,800.00

This study focuses on China’s Penicillin industry forecasts. In the two past decades, the ... long-term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...

July 2020 85 pages
Prescription Drugs Industry Forecasts - China Focus US$ 1,800.00

This study focuses on China’s Prescription Drugs industry forecasts. In the two past decades, the ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...

July 2020 93 pages
Cephalosporin Companies in China US$ 1,800.00

This study focuses on China’s Cephalosporin industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...

July 2020 59 pages
Penicillin Companies in China US$ 1,800.00

This study focuses on China’s Penicillin industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...

July 2020 77 pages
Prescription Drugs Companies in China US$ 1,800.00

This study focuses on China’s Prescription Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...

July 2020 73 pages
Acne Vulgaris pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Acne Vulgaris PIPELINE HIGHLIGHTS Acne Vulgaris is one of the widely researched conditions during 2020 with 42 companies actively focusing on realizing pipeline’s potential. Development of Acne V...

July 2020 210 pages
Acromegaly pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Acromegaly PIPELINE HIGHLIGHTS Acromegaly is one of the widely researched conditions during 2020 with 22 companies actively focusing on realizing pipeline’s potential. Development of Acromegaly m...

July 2020 96 pages
Actinic Keratosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Actinic Keratosis PIPELINE HIGHLIGHTS Actinic Keratosis is one of the widely researched conditions during 2020 with 10 companies actively focusing on realizing pipeline’s potential. Development o...

July 2020 59 pages
Alcoholic Hepatitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Alcoholic Hepatitis PIPELINE HIGHLIGHTS Alcoholic Hepatitis is one of the widely researched conditions during 2020 with 14 companies actively focusing on realizing pipeline’s potential. Developme...

July 2020 72 pages
Alopecia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Alopecia PIPELINE HIGHLIGHTS Alopecia is one of the widely researched conditions during 2020 with 40 companies actively focusing on realizing pipeline’s potential. Development of Alopecia medicin...

July 2020 200 pages
Anemia in Chronic Kidney Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Anemia in Chronic Kidney Disease PIPELINE HIGHLIGHTS Anemia in Chronic Kidney Disease is one of the widely researched conditions during 2020 with 25 companies actively focusing on realizing pipel...

July 2020 124 pages
Angina (Angina Pectoris) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Angina (Angina Pectoris) PIPELINE HIGHLIGHTS Angina (Angina Pectoris) is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential....

July 2020 53 pages
Aplastic Anemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Aplastic Anemia PIPELINE HIGHLIGHTS Aplastic Anemia is one of the widely researched conditions during 2020 with 15 companies actively focusing on realizing pipeline’s potential. Development of Ap...

July 2020 84 pages
Arrhythmias pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Arrhythmias PIPELINE HIGHLIGHTS Arrhythmias is one of the widely researched conditions during 2020 with 15 companies actively focusing on realizing pipeline’s potential. Development of Arrhythmia...

July 2020 72 pages
Arterial Thrombosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Arterial Thrombosis PIPELINE HIGHLIGHTS Arterial Thrombosis is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Developmen...

July 2020 48 pages
Atrial Fibrillation pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Atrial Fibrillation PIPELINE HIGHLIGHTS Atrial Fibrillation is one of the widely researched conditions during 2020 with 23 companies actively focusing on realizing pipeline’s potential. Developme...

July 2020 121 pages
Atypical Hemolytic Uremic Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Atypical Hemolytic Uremic Syndrome PIPELINE HIGHLIGHTS Atypical Hemolytic Uremic Syndrome is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pi...

July 2020 63 pages
Axillary Hyperhidrosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Axillary Hyperhidrosis PIPELINE HIGHLIGHTS Axillary Hyperhidrosis is one of the widely researched conditions during 2020 with 7 companies actively focusing on realizing pipeline’s potential. Deve...

July 2020 51 pages
Behcet Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Behcet Disease PIPELINE HIGHLIGHTS Behcet Disease is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Behce...

July 2020 47 pages
Bullous Pemphigoid pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Bullous Pemphigoid PIPELINE HIGHLIGHTS Bullous Pemphigoid is one of the widely researched conditions during 2020 with 10 companies actively focusing on realizing pipeline’s potential. Development...

July 2020 59 pages
Burns pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Burns PIPELINE HIGHLIGHTS Burns is one of the widely researched conditions during 2020 with 32 companies actively focusing on realizing pipeline’s potential. Development of Burns medicines is ide...

July 2020 146 pages
Celiac Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Celiac Disease PIPELINE HIGHLIGHTS Celiac Disease is one of the widely researched conditions during 2020 with 19 companies actively focusing on realizing pipeline’s potential. Development of Celi...

July 2020 89 pages
Colitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Colitis PIPELINE HIGHLIGHTS Colitis is one of the widely researched conditions during 2020 with 27 companies actively focusing on realizing pipeline’s potential. Development of Colitis medicines...

July 2020 112 pages
Constipation pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Constipation PIPELINE HIGHLIGHTS Constipation is one of the widely researched conditions during 2020 with 16 companies actively focusing on realizing pipeline’s potential. Development of Constipa...

July 2020 82 pages
Contact Dermatitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Contact Dermatitis PIPELINE HIGHLIGHTS Contact Dermatitis is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potential. Development...

July 2020 40 pages
Contrast Induced Nephropathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Contrast Induced Nephropathy PIPELINE HIGHLIGHTS Contrast Induced Nephropathy is one of the widely researched conditions during 2020 with 3 companies actively focusing on realizing pipeline’s pot...

July 2020 35 pages
Coronary Artery Disease (CAD) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Coronary Artery Disease (CAD) PIPELINE HIGHLIGHTS Coronary Artery Disease (CAD) is one of the widely researched conditions during 2020 with 39 companies actively focusing on realizing pipeline’s...

July 2020 176 pages
Critical Limb Ischemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Critical Limb Ischemia PIPELINE HIGHLIGHTS Critical Limb Ischemia is one of the widely researched conditions during 2020 with 27 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 121 pages
Deep Vein Thrombosis (DVT) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Deep Vein Thrombosis (DVT) PIPELINE HIGHLIGHTS Deep Vein Thrombosis (DVT) is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potenti...

July 2020 46 pages
Diabetic Gastroparesis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Diabetic Gastroparesis PIPELINE HIGHLIGHTS Diabetic Gastroparesis is one of the widely researched conditions during 2020 with 10 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 62 pages
Diarrhea pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Diarrhea PIPELINE HIGHLIGHTS Diarrhea is one of the widely researched conditions during 2020 with 29 companies actively focusing on realizing pipeline’s potential. Development of Diarrhea medicin...

July 2020 145 pages
Dilated Cardiomyopathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Dilated Cardiomyopathy PIPELINE HIGHLIGHTS Dilated Cardiomyopathy is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential. Deve...

July 2020 54 pages
Down Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Down Syndrome PIPELINE HIGHLIGHTS Down Syndrome is one of the widely researched conditions during 2020 with 13 companies actively focusing on realizing pipeline’s potential. Development of Down S...

July 2020 75 pages
End Stage Kidney Disease (ESRD) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 End Stage Kidney Disease (ESRD) PIPELINE HIGHLIGHTS End Stage Kidney Disease (ESRD) is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline...

July 2020 52 pages
Enterocolitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Enterocolitis PIPELINE HIGHLIGHTS Enterocolitis is one of the widely researched conditions during 2020 with 11 companies actively focusing on realizing pipeline’s potential. Development of Entero...

July 2020 60 pages
Eosinophilic Esophagitis (EoE) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Eosinophilic Esophagitis (EoE) PIPELINE HIGHLIGHTS Eosinophilic Esophagitis (EoE) is one of the widely researched conditions during 2020 with 18 companies actively focusing on realizing pipeline’...

July 2020 79 pages
Epidermolysis Bullosa pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Epidermolysis Bullosa PIPELINE HIGHLIGHTS Epidermolysis Bullosa is one of the widely researched conditions during 2020 with 33 companies actively focusing on realizing pipeline’s potential. Devel...

July 2020 156 pages
Fanconi Anemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Fanconi Anemia PIPELINE HIGHLIGHTS Fanconi Anemia is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Fanco...

July 2020 50 pages
Functional Dyspepsia (Non Ulcer Dyspepsia) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Functional Dyspepsia (Non Ulcer Dyspepsia) PIPELINE HIGHLIGHTS Functional Dyspepsia (Non Ulcer Dyspepsia) is one of the widely researched conditions during 2020 with 4 companies actively focusing...

July 2020 42 pages
Gastric Ulcers pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Gastric Ulcers PIPELINE HIGHLIGHTS Gastric Ulcers is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Gastr...

July 2020 42 pages
Gastritis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Gastritis PIPELINE HIGHLIGHTS Gastritis is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Gastritis medic...

July 2020 58 pages
Gastroenteritis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Gastroenteritis PIPELINE HIGHLIGHTS Gastroenteritis is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Gas...

July 2020 58 pages
Gingivitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Gingivitis PIPELINE HIGHLIGHTS Gingivitis is one of the widely researched conditions during 2020 with 3 companies actively focusing on realizing pipeline’s potential. Development of Gingivitis me...

July 2020 35 pages
Graves Diseases pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Graves Diseases PIPELINE HIGHLIGHTS Graves Diseases is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential. Development of Gra...

July 2020 56 pages
Hepatic Encephalopathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook US$ 1,599.00

2020 Hepatic Encephalopathy PIPELINE HIGHLIGHTS Hepatic Encephalopathy is one of the widely researched conditions during 2020 with 12 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 79 pages

Filters

Search

Publishers

1
165
1
5
174
29
142
38
26
1
27
17
4
1
2
10
2
9
2
421
3
19
1
17
373
474
4
2
1
1
2
16
1,200
6
89
166
6
84
31
2
36
3
5
4
17
118
187
13
16
4
2
7
13
110
2
10
34
12
10
4
2
17
4
73
2
1
11
32
7
8
4
19
118
27
2
1
19
4
7
3
325
8
1
1
23
31
4
11
6
1
514
24
2
5
25
44
195
17
15
13
5
19

Regions

586
268
158
54
50
44
44
42
40
20
18
17
16
16
16
15
14
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
12
12
12
11
11
11
10
10
9
8
8
7
6
6
5
4
3
188
7
9
5
4
4
7
5
11
9
9
6
9
6
5
8
10
8
4
4
4
4
4
3
3
3
3
3
3
1
1
11
10
178
3
11
14
11
16
9
6
16
14
7
150
242
2,903

Price

Date

Pages

Offers

4
1
1
513